Swedish Formula for Enlarged Prostate
VIXÖVA™ is a clinically tested formula for the relief of Prostatitis and Benign Prostate Hyperplasia also known as BPH or enlarged prostate. The VIXÖVA™ formula was developed in Sweden and is the most recommended non prescription formulation by European and Asian Doctors.

Unlike most prostate drugs on the market today, VIXÖVA™ does not have any negative side effects; on the contrary, in addition to alleviating prostate issues, VIXÖVA™ has beneficial sexual effects. Men typically report increased semen production and better sexual response and pleasure during sex when taking VIXÖVA™.


Has Pollëxia™ been studied?
The Pollëxia™ extract has undergone many studies over the past 40 years. To view some of the studies, click on the following links:

A Critical Review of Pollëxia™ for Symptomatic relief of Lower Urinary Tract Symptoms (LUTS) in Men.

A Study of Pollëxia™ for Symptomatic relief of Lower Urinary Tract Symptoms (LUTS) in Men.

Effect of Pollëxia™ Extract (VIXÖVA™) on the Function of Urinary Bladder in Conscious Rats.

Comparison of Saw Palmetto (Extract and whole berry) with Pollëxia™ on Prostate Growth in Rats.

Effects of Pollëxia™ on Sex-hormone-induced Nonbacterial Prostatitis in Rats.

Effects of Pollëxia™ on Non-Bacterial Prostatitis in Rats.

Results of Treatement with VIXÖVA™ in Prostatodyniad and Chronic Prostatitis.



What type of Symptoms can VIXÖVA™ alleviate?
VIXÖVA™ has been shown to help alleviate the following symptoms:
  • Excessive urges to urinate, including during the night.
  • Pain associated with prostate inflammation or enlargement.
  • Blood in urine.
  • Lack of seminal fluid production.
As with any symptom of disease, please consult your physician prior to taking any medication or prostate supplements.

Does VIXÖVA™ have any side effects?
Unlike pharmaceutical products, VIXÖVA™ does not have negative side effects but instead provides positive side effects such as increased seminal fluid production and more intense pleasure during sexual activity.